overweight. Obesity, unspecified
Conditions
Interventions
Intervention 1: placebo three tablets daily. Intervention 2: acarbose tablet 100 mg three tablets daily.
Placebo
Treatment - Drugs
placebo three tablets daily
acarbose tablet 100 mg three tablets daily
Sponsors
Kerman medical university
Excir company
Eligibility
Sex/Gender
All
Age
18 Years to 149 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria were age equal or more than 18 years, willingness to participate in the study, BMI (weight[kg]/ height[m]2 ) between 25-35, no evidence of cardiovascular disease, diabetes, gastrointestinal disease (IBD, intestinal ulcers, bowel obstruction), liver disease and renal disease, no history of medication for lowering weight, women should not be pregnant or milking. The exclusion criteria were no desire to continue the treatment, development of renal, gastrointestinal and liver disease during treatment and beginning to utilize antihypertensive drugs such as ß blocker and thiazides.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| BMI. Timepoint: monthly. Method of measurement: meter and weighting scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Fbs, TG, Cholestrol. Timepoint: every three mounth. Method of measurement: lab test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Akram Nakhaee
Kerman Medical university
Outcome results
None listed